טוען...
Imaging DNA Damage Repair In Vivo After (177)Lu-DOTATATE Therapy
Molecular radiotherapy using (177)Lu-DOTATATE is a most effective treatment for somatostatin receptor–expressing neuroendocrine tumors. Despite its frequent and successful use in the clinic, little or no radiobiologic considerations are made at the time of treatment planning or delivery. On positive...
שמור ב:
| הוצא לאור ב: | J Nucl Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Society of Nuclear Medicine
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7198382/ https://ncbi.nlm.nih.gov/pubmed/31757844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.119.232934 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|